Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/16/2003WO2002077643A3 Detection of inflammations
10/16/2003WO2002077262A3 Method and apparatus for the automated generation of nucleic acid ligands
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002072868A3 Methods and tools for nucleic acid sequence analysis selection and generation
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068680A3 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2002068452A3 Method of isolating charged compounds, especially peptides and proteins
10/16/2003WO2002066684A3 Genome-based personalized medicine
10/16/2003WO2002064838A3 Amplified cancer gene wip1
10/16/2003WO2002064816A3 Multiple determinants for metabolic phenotypes
10/16/2003WO2002062821A8 Peptide or protein microassay method and apparatus
10/16/2003WO2002061140A3 Competitive population normalization for comparative analysis of nucleic acid samples
10/16/2003WO2002059606A3 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection
10/16/2003WO2002059375A3 Determination of ugt2b7 gene polymorphisms for predicting ugt2b7 substrate toxicity and for optimising drug dosage
10/16/2003WO2002057495A3 A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments
10/16/2003WO2002056670A3 Activatable imaging probes
10/16/2003WO2002054064A3 Method for screening for progesterone receptor isoform-specific ligands
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002036815A3 Genetic analysis of microorganisms
10/16/2003WO2002033121A3 Test for the diagnosis of diabetes and compounds for the treatment thereof
10/16/2003WO2002031189A3 Model system for the vivo study of apoptosis
10/16/2003WO2002029098A3 Genetic factors affecting the outcome of viral infections
10/16/2003WO2002024945A3 Diagnostic assay for boar taint
10/16/2003WO2002022778A3 Ab initio physics-based gene identification method
10/16/2003WO2002018631A3 Diagnosis of illnesses or predisposition to certain illnesses
10/16/2003WO2002004680A3 Real-time sequence determination
10/16/2003WO2001098537A3 Nucleic acid accessible hybridization sites
10/16/2003WO2001096607A3 Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030196214 Isolating mRNA from plant growing both under normal and drought conditions, reverse transcripting mRNAs to cDNA, transferring genes into plants; genes obtained from cell differentiation in different conditions
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195153 Comprises metalloproteinase (stromelysin) inhibitors
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194818 Platelet immunoglobulin bead suspension and flow cytometry
10/16/2003US20030194808 Controlled electroporation and mass transfer across cell membranes
10/16/2003US20030194797 Metalloproteinase ADAM 22
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194786 Used for genetic engineering; involving hydrogen bonds
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194763 End selection in directed evolution
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194758 Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
10/16/2003US20030194754 Method for the diagnosis and prognosis of malignant diseases
10/16/2003US20030194750 For inhibiting glycogen synthase kinase 3 (GSK3) in non-neoplastic conditions, via increasing protein kinase G (PKG) activity and inhibiting cGMP phosphodiesterase (PDE)
10/16/2003US20030194749 Wortmannin derivatives as probes of cellular proteins and processes
10/16/2003US20030194746 For diagnosis, prognosis, prophylaxis
10/16/2003US20030194740 System and method for nucleic acid sequencing by polymerase synthesis
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194735 Using specific primers
10/16/2003US20030194734 For determining gene expression patterns of relevant cells; protein based
10/16/2003US20030194733 Cancer diagnostic panel
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194730 For producing and distinguishing basmati rice from other strains
10/16/2003US20030194729 Conantokins
10/16/2003US20030194728 Description of genetic variants of the Solute Carrier Family 26, Member 2 (SLC26A2) gene
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194726 Thermus oshimai nucleic acid polymerases
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003US20030194724 Evaluation of sequence information to characterize putative heterozygous indel mutations to identify mixed-base presence resulting from allelic differences; used to resolve single nucleotide polymorphisms, insertions, deletions
10/16/2003US20030194723 Relates to hybridization assay probes, capture probes, amplification primers, nucleic acid compositions, methods and kits useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium
10/16/2003US20030194722 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
10/16/2003US20030194721 Differentially expressed when foam cells are treated with oxidized low-density lipoprotein and LPS as associated with atherosclerosis
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194719 Tpst-assay for diagnosis of autism and related disorders
10/16/2003US20030194717 Mass labels
10/16/2003US20030194713 NP95 - Nucleic acids and polypeptide polymorphic variants with an amino acid sequence identity of above 90% that bind to antibodies and specifically hybridize under stringent hybridization conditions to an antisense strand
10/16/2003US20030194711 Identifying sequence diversity in a gene or expressed sequence wherein hybridization differences arising from polymorphic bases in analogous expressed sequences are identified between nucleotide populations
10/16/2003US20030194710 Method for making a molecularly smooth surface
10/16/2003US20030194709 A genetic analysis chip having a hydrophobic zone, bounding a hydrophilic zone in which a genetic sample can be analyzed
10/16/2003US20030194706 Methods and kits for the sequential elution of families of extension products from one or more substrates
10/16/2003US20030194704 Predicting, confirming and displaying functional regions from genomic sequence data are used for gene expression analysis
10/16/2003US20030194703 Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, and development of therapeutics
10/16/2003US20030194701 Predicting phenotypic classes of lymphomas, such as lymphoma type or treatment outcome, for lymphoma samples based on gene expression profiles
10/16/2003US20030194700 Comprising probes spotted on a plate at a plurality of positions by using a binding agent
10/16/2003US20030194699 Multiplex method for nucleic acid detection
10/16/2003US20030194697 Determining the affinity between binding partners or a property of one of the partners
10/16/2003US20030194414 Replikin peptides and antibodies therefore
1 ... 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 ... 3003